These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 21352202)

  • 1. Immunomodulatory properties and therapeutic application of mesenchymal stem cells.
    Shi M; Liu ZW; Wang FS
    Clin Exp Immunol; 2011 Apr; 164(1):1-8. PubMed ID: 21352202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.
    Selmani Z; Naji A; Zidi I; Favier B; Gaiffe E; Obert L; Borg C; Saas P; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F
    Stem Cells; 2008 Jan; 26(1):212-22. PubMed ID: 17932417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent research advance in immunomodulatory function of mesenchymal stem cells on immune cells].
    Wei YJ; Lin YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1079-83. PubMed ID: 20723333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory properties of bone marrow mesenchymal stem cells.
    Mohanty A; Polisetti N; Vemuganti GK
    J Biosci; 2020; 45():. PubMed ID: 32713861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.
    Menard C; Pacelli L; Bassi G; Dulong J; Bifari F; Bezier I; Zanoncello J; Ricciardi M; Latour M; Bourin P; Schrezenmeier H; Sensebé L; Tarte K; Krampera M
    Stem Cells Dev; 2013 Jun; 22(12):1789-801. PubMed ID: 23339531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mesenchymal stem cells and their immunological properties].
    Lisianyĭ MI
    Fiziol Zh (1994); 2013; 59(3):126-34. PubMed ID: 23957174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
    Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F
    Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
    Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
    Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stromal Cells on Natural Killer Cells.
    Hu CD; Kosaka Y; Marcus P; Rashedi I; Keating A
    Stem Cells Dev; 2019 Jul; 28(14):933-943. PubMed ID: 31122145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.
    Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH
    Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mesenchymal stem cells modulate allogeneic immune cell responses.
    Aggarwal S; Pittenger MF
    Blood; 2005 Feb; 105(4):1815-22. PubMed ID: 15494428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory activity of mesenchymal stem cells.
    Kaplan JM; Youd ME; Lodie TA
    Curr Stem Cell Res Ther; 2011 Dec; 6(4):297-316. PubMed ID: 21190531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between human mesenchymal stem cells and natural killer cells.
    Sotiropoulou PA; Perez SA; Gritzapis AD; Baxevanis CN; Papamichail M
    Stem Cells; 2006 Jan; 24(1):74-85. PubMed ID: 16099998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory properties of mesenchymal stromal cells.
    Nauta AJ; Fibbe WE
    Blood; 2007 Nov; 110(10):3499-506. PubMed ID: 17664353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance.
    Contreras-Kallens P; Terraza C; Oyarce K; Gajardo T; Campos-Mora M; Barroilhet MT; Álvarez C; Fuentes R; Figueroa F; Khoury M; Pino-Lagos K
    Ann N Y Acad Sci; 2018 Apr; 1417(1):35-56. PubMed ID: 28700815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells.
    Chen PM; Yen ML; Liu KJ; Sytwu HK; Yen BL
    J Biomed Sci; 2011 Jul; 18(1):49. PubMed ID: 21762539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
    Zimmermann JA; Hettiaratchi MH; McDevitt TC
    Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.
    Cui R; Rekasi H; Hepner-Schefczyk M; Fessmann K; Petri RM; Bruderek K; Brandau S; Jäger M; Flohé SB
    Stem Cell Res Ther; 2016 Jul; 7(1):88. PubMed ID: 27388156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.